Zobrazeno 1 - 10
of 186
pro vyhledávání: '"Ruchan Uslu"'
Autor:
Gulcan Bulut, Merve Guner Oytun, Elvina Almuradova, Mustafa Harman, Ruchan Uslu, Bulent Karabulut
Publikováno v:
PLoS ONE, Vol 16, Iss 11 (2021)
Background The aim of the study is to reveal the contribution of complete response (CR) to treatment to overall survival (OS) in patients with unresectable metastatic colorectal cancer. In addition, to evaluate progression-free survival (PFS) in pati
Externí odkaz:
https://doaj.org/article/be133167b4e84d62ad4d93c155ed2563
Publikováno v:
European Journal of Breast Health, Vol 14, Iss 4, Pp 211-217 (2018)
Objective: Inflammatory breast cancer (IBC) has an unfavourable prognosis despite the advances made in the treatment of breast cancer. Our study aimed to define immunohistochemistry-based surrogate subtype distribution to determine whether the breast
Externí odkaz:
https://doaj.org/article/7ceecf9ea4584fd8a281e9300618c3f2
Autor:
Burcu Cakar, Ugur Muslu, Emir Bozkurt, Harika Atmaca, Burcak Karaca, Bulent Karabulut, Ruchan Uslu
Publikováno v:
Journal of Oncological Sciences, Vol 4, Iss 2, Pp 65-69 (2018)
Aim: Glioblastoma multiforme (GBM) is the most common glial tumor. Angiogenesis which provides nutrient and oxygen support to proliferating cells play an essential role in GBM development, proliferation and metastasis. The development of antiangiogen
Externí odkaz:
https://doaj.org/article/453d0ca370f7457b99d6aedb4578bffa
Autor:
Eda Acikgoz, Ummu Guven, Fahriye Duzagac, Ruchan Uslu, Mikail Kara, Burak Cem Soner, Gulperi Oktem
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0141090 (2015)
Trabectedin (Yondelis, ET-743) is a marine-derived tetrahydroisoquinoline alkaloid. It is originally derived from the Caribbean marine tunicate Ecteinascidia turbinata and currently produced synthetically. Trabectedin is active against a variety of t
Externí odkaz:
https://doaj.org/article/a10319aeaeb1411db0cd4eb779c27fef
Autor:
Ahmet Bilici, Mukremin Uysal, Serkan Menekse, Semih Akin, Fatih Yildiz, Merve Turan, Sema Sezgin Goksu, Ismail Beypinar, Teoman Sakalar, Mustafa Değirmenci, Dilek Erdem, Gul Basaran, Omer Fatih Olmez, Nilufer Avci, Deniz Tural, Abdullah Sakin, Sema Turker, Atakan Demir, Suleyman Temiz, Muhammed Ali Kaplan, Mutlu Dogan, Ozgur Tanriverdi, Irem Bilgetekin, Havva Yesil Cinkir, Ozgur Acikgoz, Semra Paydas, Ruchan Uslu, Serdar Turhal
© 2021 Taylor & Francis Group, LLC.Purpose: This study evaluated the efficacy and safety of everolimus (EVE) plus exemestane (EXE) in hormone-receptor positive (HR+), human epidermal growth factor receptor-2-negative (HER2−) metastatic breast canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc88869b3476dea5a33f45cbc1f4df24
https://hdl.handle.net/11454/77155
https://hdl.handle.net/11454/77155
Publikováno v:
Nutrition and Cancer. 72:202-208
EgeUn###
Aim: The purpose of this study was to identify the nutritional and performance status of Pancreatic Cancer (PanCa) patients and to determine the relationship between these parameters and their survival time. Material and Methods: Ninety
Aim: The purpose of this study was to identify the nutritional and performance status of Pancreatic Cancer (PanCa) patients and to determine the relationship between these parameters and their survival time. Material and Methods: Ninety
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c1d3b45626ceb115fc3db666586d325
https://doi.org/10.1080/01635581.2019.1634217
https://doi.org/10.1080/01635581.2019.1634217
Autor:
Mustafa Harman, Ruchan Uslu, Elvina Almuradova, Bulent Karabulut, Gulcan Bulut, Merve Güner Oytun
Publikováno v:
PLoS ONE, Vol 16, Iss 11, p e0259622 (2021)
PLoS ONE, Vol 16, Iss 11 (2021)
PLoS ONE
PLoS ONE, Vol 16, Iss 11 (2021)
PLoS ONE
Background The aim of the study is to reveal the contribution of complete response (CR) to treatment to overall survival (OS) in patients with unresectable metastatic colorectal cancer. In addition, to evaluate progression-free survival (PFS) in pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82cd730661dd31c0899bd12afd1b989e
https://doaj.org/article/754eb08cb1464cd2ab4647227162832c
https://doaj.org/article/754eb08cb1464cd2ab4647227162832c
Autor:
Burcak Karaca, Emir Bozkurt, Ugur Muslu, Burcu Çakar, Harika Atmaca, Bulent Karabulut, Ruchan Uslu
Publikováno v:
Journal of Oncological Sciences, Vol 4, Iss 2, Pp 65-69 (2018)
Aim: Glioblastoma multiforme (GBM) is the most common glial tumor. Angiogenesis which provides nutrient and oxygen support to proliferating cells play an essential role in GBM development, proliferation and metastasis. The development of antiangiogen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8362add5a9299e223e4c9e9a7726acc2
http://www.sciencedirect.com/science/article/pii/S2452336418300359
http://www.sciencedirect.com/science/article/pii/S2452336418300359
Autor:
Şaziye Rüçhan Sertöz, H Aytac Erdem, Solid Organ Malignancy, Oğuz Reşat Sipahi, Ruchan Uslu, Hüsnü Pullukçu, Meltem Taşbakan, Sercan Ulusoy, Tansu Yamazhan
Publikováno v:
International Journal of Hematology and Oncology. 27:213-219
WOS: 000419586300002
The aim of this study was to screen the patients with solid organ malignancy for HBV (Hepatitis B virus) infection before the start of chemotherapy and follow up in the oncology department of our setting. All cases admitted
The aim of this study was to screen the patients with solid organ malignancy for HBV (Hepatitis B virus) infection before the start of chemotherapy and follow up in the oncology department of our setting. All cases admitted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25e0c8a71f79e2bd843dd271346c056c
https://doi.org/10.4999/uhod.171914
https://doi.org/10.4999/uhod.171914
Autor:
Esin, Oktay, Gizem Donmez, Yalcin, Sumeyye, Ekmekci, Dudu Solakoglu, Kahraman, Abdullah, Yalcin, Mustafa, Degirmenci, Ahmet, Dirican, Zeynep, Altin, Ozlem, Ozdemir, Zeki, Surmeli, Gulden, Diniz, Semin, Ayhan, Gulcan, Bulut, Atike, Erdogan, Ruchan, Uslu
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 24(2)
Gastroenteropancreatic tumors (GEPNETs) is a heterogeneous disease with variable clinical course. While promising therapeutic options exist for other adult cancers, there are no new molecular-based treatments developed for GEPNETs. One of the main ta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f286670471db558e48095a02118eb043
https://pubmed.ncbi.nlm.nih.gov/31128036
https://pubmed.ncbi.nlm.nih.gov/31128036